Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 9 more sites

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Jan 03, 2023 10:08pm

163 Views

Post# 35201962

RE:RE:RE:9 more sites

That is interesting.

enriquesuave wrote:
A few years ago Endocyte got into a partnership with Novartis after good interim PH2 data. Within 12 months they got bought out and MC went from $50 million gradually up until a $2.1 Billion USD buyout. FDA approval only came about 2-3 years after buyout. That is 42 time MC and SP appreciation over 12 months. Anything is possible. IMHO

CancerSlayer wrote: Per the article:

"We are approximately halfway through enrollment, with 11 clinical study sites currently enrolling patients and plans to add up to an additional nine clinical study sites in 2023 for a total of up to 20 clinical study sites in Canada and the United States,” according to Dr. Mandel.

Good point Dawg....Having limited cash on hand & yet still planning to add "9" additional sites hints at one likely event....& so I'm hopeful for seeing much more than a BTD/AA this year. As skys1 stated, Big Pharma has likely shown its hand & if all goes smoothly, I wouldn't be surprised to see a solid partnership unfold in the next 12 months. Good luck....